Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines

International Journal of Cancer

Volumn 97, Issue 5, 2002, Pages 584-592

  Sartorius, Ute A ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Bcl 2; Chemotherapy; Mitochondria; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SMALL CELL; CASPASES; CELL SURVIVAL; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FAS LIGAND PROTEIN; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037050735     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10096     Document Type: Article

References (69)

1. Cancer statistics, 1994
2. Small cell lung cancer
3. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research
4. Apoptosis in cancer therapy: Crossing the threshold
5. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells
6. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
7. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells
8. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid
9. Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy
10. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore
11. Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy
12. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
13. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
14. Molecular characterization of mitochondrial apoptosis-inducing factor
15. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
16. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
17. Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
18. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
19. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
20. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
21. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
22. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
23. BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
24. L antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
25. bcl-2 antisense therapy chemosensitizes human melanoma in SCD mice
26. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
27. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
28. The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis
29. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
30. BCL-2 family members and the mitochondria in apoptosis
31. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
32. Mitochondrial control of cell death
33. Bcl-2-mediated drug resistance: Inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription
34. Small cell carcinomas of the lung express the Bcl-2 protein
35. Expression of bcl-2 in small cell lung carcinoma cells
36. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas
37. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2
38. Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines
39. FLICE is predominantly expressed as two functionally active isoforms, caspasae-8/a and caspase-8/b
40. Monoclonal antibody-mediated tumor regression by induction of apoptosis
41. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex
42. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
43. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
44. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
45. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
46. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
47. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
48. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/APO-1, and DR3 and is lethal prenatally
49. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
50. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
51. Cytotoxic drugs, programmed cell death, and the immune system: Defining new roles in an old play
52. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
53. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma
54. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis
55. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
56. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor
57. Two CD95 (APO-1/Fas) signaling pathways
58. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis
59. Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis
60. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
61. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis
62. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
63. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
64. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection
65. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin
66. MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross-resistance
67. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis
68. L anti-sense treatment
69. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems